<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Chemistry</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C39D2A11-F206-4EC9-9AAC-844865F2D6B1"><gtr:id>C39D2A11-F206-4EC9-9AAC-844865F2D6B1</gtr:id><gtr:firstName>Dominic</gtr:firstName><gtr:surname>Campopiano</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FG53045X%2F1"><gtr:id>AD68FA76-9AA3-4DDF-B700-747046E3BFB5</gtr:id><gtr:title>Sphingolipid biosynthesis in man and microbes</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/G53045X/1</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>19438</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>This was a travel grant that allowed me to visit my USA collaborators in Washington DC and attend the key scientific meetings in the sphingolipid field.</gtr:description><gtr:firstYearOfImpact>2008</gtr:firstYearOfImpact><gtr:id>0001B6CB-7EA2-421D-A29E-53B84F994544</gtr:id><gtr:impactTypes><gtr:impactType>Societal</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56deb6ec3e1805.40364518</gtr:outcomeId><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We used this travel grant to send scientists from my group to a collaborating lab in Bethesda USA - Prof. Teresa Dunn. We developed structural and functional studies of the enzyme target. We also used this grant to collaborate and publish with a leading Japanese group.</gtr:description><gtr:exploitationPathways>We also used the funding to attend Deater Family meetings - a family affected by a rare neuropathic disease HSN1.</gtr:exploitationPathways><gtr:id>EA8F12A0-F9ED-44DE-BC46-81F3901AE990</gtr:id><gtr:outcomeId>56deb78c125806.29496745</gtr:outcomeId><gtr:sectors><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>AE11ED30-2C24-4D75-8FD2-F77CAAFD6E71</gtr:id><gtr:title>Role of a conserved arginine residue during catalysis in serine palmitoyltransferase.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a53f435a91bfb40375ee2744a861c380"><gtr:id>a53f435a91bfb40375ee2744a861c380</gtr:id><gtr:otherNames>Lowther J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>pm_55f93b993b9c367f1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18FDDE2D-3D92-4405-A639-A5816411F041</gtr:id><gtr:title>The pyridoxal 5'-phosphate (PLP)-dependent enzyme serine palmitoyltransferase (SPT): effects of the small subunits and insights from bacterial mimics of human hLCB2a HSAN1 mutations.</gtr:title><gtr:parentPublicationTitle>BioMed research international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c5d09790771a4573bf6cfe317cba45d"><gtr:id>5c5d09790771a4573bf6cfe317cba45d</gtr:id><gtr:otherNames>Beattie AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>5444cee99a0a37.92010746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57AAD465-E43B-4C02-9C5F-5C0F7CF3E9FF</gtr:id><gtr:title>The chemical basis of serine palmitoyltransferase inhibition by myriocin.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7910d6faf972253feb3ff9258a516d3a"><gtr:id>7910d6faf972253feb3ff9258a516d3a</gtr:id><gtr:otherNames>Wadsworth JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>5675d8b85a397</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D143670-252B-4538-A408-8B306B15C573</gtr:id><gtr:title>l-Penicillamine is a mechanism-based inhibitor of serine palmitoyltransferase by forming a pyridoxal-5&amp;acirc;?&amp;sup2;-phosphate-thiazolidine adduct</gtr:title><gtr:parentPublicationTitle>MedChemComm</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a53f435a91bfb40375ee2744a861c380"><gtr:id>a53f435a91bfb40375ee2744a861c380</gtr:id><gtr:otherNames>Lowther J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>5444ceea0343e0.76520884</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6AAA295-1F16-43AA-AA0D-CED642AC992E</gtr:id><gtr:title>Structural, mechanistic and regulatory studies of serine palmitoyltransferase.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a53f435a91bfb40375ee2744a861c380"><gtr:id>a53f435a91bfb40375ee2744a861c380</gtr:id><gtr:otherNames>Lowther J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>5444cee9c98ca6.40220316</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/G53045X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>